These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3226575)

  • 1. [Acute severe coronary insufficiency during intravenous therapy with buflomedil hydrochloride. Description of 4 cases].
    Romanò M; Spinelli A; Muzio L; Cazzani E; Baldini MR
    Minerva Cardioangiol; 1988 Sep; 36(9):451-5. PubMed ID: 3226575
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
    Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V; Margheriti R; Matone P; Morrieri C; Rugolo A; Corsi V
    Clin Ter; 1986 Jun; 117(6):499-509. PubMed ID: 3527536
    [No Abstract]   [Full Text] [Related]  

  • 4. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
    Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H; Wehselau H
    Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R; Klaus D
    Vasa; 1984; 13(2):171-4. PubMed ID: 6741240
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experimentation with a new vasodilator: cinepazide maleate in arterial diseases of the lower limbs].
    Warembourg G; Carre A; Ginestet A; Lambert M
    Lille Med; 1976 Dec; 21 Suppl 4():898-901. PubMed ID: 1018614
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V; Mammarella A; Alessandrini A; Barlattani M
    Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myoclonus during treatment with buflomedil].
    Leys D; Pavy G; Bourgeois P; Petit H
    Therapie; 1985; 40(6):481. PubMed ID: 4089790
    [No Abstract]   [Full Text] [Related]  

  • 10. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F; Briguglio E; Di Marco V; Swat M; Materia G; Intilisano A
    J Int Med Res; 1986; 14(3):115-23. PubMed ID: 3721052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Buflomedil chlorhydrate in peripheral vasculopathies].
    Dall'Antonia F; Perbellini A; Adami CA; Dal Cortivo G; Bucci S
    Clin Ter; 1986 Dec; 119(5):379-85. PubMed ID: 2951055
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L; Gandolfo AM; Utz C
    MMW Munch Med Wochenschr; 1984 Mar; 126(9):247-8. PubMed ID: 6425678
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S; Manganaro A; Barbera MC; Cento D; Buda D; Arrigo F; Consolo F
    Minerva Cardioangiol; 1986 Nov; 34(11):745-9. PubMed ID: 2949163
    [No Abstract]   [Full Text] [Related]  

  • 15. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S; Ferulano GP; Vanni L; Dilillo S; Picilli M; D'Alessio E
    Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J; Intaglietta M; Messmer K
    Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P; Pagratis N
    Angiology; 1981 Oct; 32(10):679-85. PubMed ID: 7325404
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G; Baldoni F; Peruzzi G; Raimondi G; Grimaldi I; Visigalli G; Gristina S; Massaro M; De Martinis L; Sangiorgi M
    Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209
    [No Abstract]   [Full Text] [Related]  

  • 20. Buflomedil: still too many fatal cardiac and neurological events.
    Prescrire Int; 2011 Apr; 20(115):99. PubMed ID: 21648214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.